Bernhard R. Winkelmann

11.3k total citations
107 papers, 4.0k citations indexed

About

Bernhard R. Winkelmann is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Bernhard R. Winkelmann has authored 107 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 30 papers in Surgery and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Bernhard R. Winkelmann's work include Lipoproteins and Cardiovascular Health (18 papers), Adipokines, Inflammation, and Metabolic Diseases (18 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers). Bernhard R. Winkelmann is often cited by papers focused on Lipoproteins and Cardiovascular Health (18 papers), Adipokines, Inflammation, and Metabolic Diseases (18 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers). Bernhard R. Winkelmann collaborates with scholars based in Germany, Austria and United States. Bernhard R. Winkelmann's co-authors include Winfried März, Bernhard O. Boehm, Michael M. Hoffmann, Markus Nauck, Bernhard Böhm, Ursula Seelhorst, Britta Wellnitz, Hubert Scharnagl, Tanja B. Grammer and Stefan Pilz and has published in prestigious journals such as The Lancet, Circulation and Annals of Internal Medicine.

In The Last Decade

Bernhard R. Winkelmann

103 papers receiving 3.9k citations

Peers

Countries citing papers authored by Bernhard R. Winkelmann

Since Specialization

Citations

This map shows the geographic impact of Bernhard R. Winkelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard R. Winkelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard R. Winkelmann more than expected).

Fields of papers citing papers by Bernhard R. Winkelmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard R. Winkelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard R. Winkelmann. The network helps show where Bernhard R. Winkelmann may publish in the future.

Co-authorship network of co-authors of Bernhard R. Winkelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard R. Winkelmann. A scholar is included among the top collaborators of Bernhard R. Winkelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard R. Winkelmann. Bernhard R. Winkelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease 2021 ·Heart ·Gilles R. Dagenais, Leanne Dyal, Jackie Bosch, Darryl P. Leong, Victor Aboyans, Scott D. Berkowitz, Deepak L. Bhatt, Stuart J. Connolly, Keith A.A. Fox, Eva Muehlhofer, Jeffrey L. Probstfield, Petr Widimský, Bernhard R. Winkelmann, Salim Yusuf, John W. Eikelboom	4
2	Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography—The LURIC study 2014 ·International Journal of Cardiology ·Hubert Scharnagl, Marcus E. Kleber, Bernd Genser, (unknown), Wilfried Renner, Gisela Weihrauch, Tanja B. Grammer, Christine Rossmann, Bernhard R. Winkelmann, Bernhard O. Boehm, Wolfgang Sattler, Winfried März, Ernst Malle	26
3	The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality 2010 ·Journal of Lipid Research ·Günther Silbernagel, Günter Fauler, Michael M. Hoffmann, Dieter Lütjohann, Bernhard R. Winkelmann, Bernhard O. Boehm, Winfried März	74
4	The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease 2008 ·Journal of Lipid Research ·Günther Silbernagel, Günter Fauler, Wilfried Renner, (unknown), Michael M. Hoffmann, Bernhard R. Winkelmann, Bernhard O. Boehm, Winfried März	70
5	Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk 2008 ·Journal of Thrombosis and Haemostasis ·Jürgen Bach, Georg Endler, Bernhard R. Winkelmann, Bernhard O. Boehm, Winfried Maerz, Christine Mannhalter, Peter Hellstern	45
6	Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study) 2008 ·Journal of Thrombosis and Haemostasis ·Michael M. Hoffmann, K. Winkler, Wilfried Renner, Bernhard R. Winkelmann, Ursula Seelhorst, Britta Wellnitz, Bernhard O. Boehm, Winfried März	31
7	Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion 2007 ·Clinica Chimica Acta ·Tatjana Stojaković, Hubert Scharnagl, Winfried März, Bernhard R. Winkelmann, Bernhard O. Boehm, O. Schmut	27
8	The serotonin transporter gene polymorphism is not associated with smoking behavior 2006 ·The Pharmacogenomics Journal ·Olivia Trummer, H Köppel, Thomas C. Wascher, (unknown), (unknown), Olaf Stanger, S Ramschak-Schwarzer, Bernhard O. Boehm, Bernhard R. Winkelmann, Winfried März, Wilfried Renner	28
9	Association of polymorphisms of platelet membrane integrins αIIbβ3 (HPA‐1b/PlA2) and α2β1 (α2807TT) with premature myocardial infarction 2005 ·Journal of Thrombosis and Haemostasis ·R. B. Zotz, Bernhard R. Winkelmann, (unknown), Bernhard O. Boehm, Winfried März, Rüdiger E. Scharf	32
10	Adiponectin serum concentrations in men with coronary artery disease: The LUdwigshafen RIsk and Cardiovascular Health (LURIC) study 2005 ·Clinica Chimica Acta ·Stefan Pilz, Winfried Maerz, Gisela Weihrauch, Karine Sargsyan, Gunter Almer, Markus Nauck, Bernhard O. Boehm, Bernhard R. Winkelmann, Harald Mangge	41
11	Association between the A?2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus 2004 ·Diabetologia ·Eleonora Simeoni, Michael M. Hoffmann, Bernhard R. Winkelmann, (unknown), Sylvain Fleury, Bernhard O. Boehm, (unknown), Giuseppe Vassalli	100
12	Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study 2004 ·Journal of Molecular Medicine ·Wilfried Renner, Markus Nauck, Bernhard R. Winkelmann, Michael M. Hoffmann, Hubert Scharnagl, (unknown), Bernhard O. Boehm, (unknown)	43
13	The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study) 2004 ·European Heart Journal ·Winfried März, Hubert Scharnagl, Michael M. Hoffmann, Bernhard O. Boehm, Bernhard R. Winkelmann	69
14	Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study 2003 ·American Heart Journal ·Elizabeth R. Hauser, Vincent Mooser, David C. Crossman, Jonathan L. Haines, (unknown), Bernhard R. Winkelmann, Silke Schmidt, William K. Scott, Allen D. Roses, Margaret A. Pericak‐Vance, Christopher B. Granger, William E. Kraus	49
15	C(−260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study 2002 ·The American Journal of Cardiology ·Markus Nauck, Bernhard R. Winkelmann, Michael M. Hoffmann, Bernhard Böhm, Heinrich Wieland, Winfried März	20
16	Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease 1999 ·American Heart Journal ·Bernhard R. Winkelmann, Andreas Russ, Markus Nauck, (unknown), Bernhard Böhm, V. Maier, Rainer B. Zotz, G. Matheis, (unknown), Heinrich Wieland, Werner Groß, D. J. Galton, Winfried März	99
17	Evolution of coronary atherosclerosis in patients with mild coronary artery disease studied by serial quantitative coronary angiography at 2 and 4 years follow-up 1997 ·European Heart Journal ·J. Vos, Pim J. de Feyter, J.Herre Kingma, Håkan Emanuelsson, (unknown), Bernhard R. Winkelmann, (unknown), (unknown)	18
18	Prevention of Reoxygenation Injury in Hypoxaemic Immature Hearts by Priming the Extracorporeal Circuit with Antioxidants 1997 ·Cardiovascular Surgery ·Kai Ihnken, Kiyozo Morita, Gerald D. Buckberg, (unknown), Bernhard R. Winkelmann, (unknown)	1
19	Left main coronary artery stenosis after aortic valve replacement 1993 ·Coronary Artery Disease ·Bernhard R. Winkelmann, Kai Ihnken, Friedhelm Beyersdorf, Lothar Eckel, (unknown), Winfried März, Günter Herrmann, (unknown), Rainer Schräder, Horst Sievert	28
20	Isometric exercise for the evaluation of vasodilatory therapy in severe congestive heart failure 1988 ·Cardiovascular Drugs and Therapy ·(unknown), Bernhard R. Winkelmann, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact